Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227968
Status:
COMPLETED
Last Update Posted:
2013-06-25
First Post:
2005-09-26
Brief Title:
Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Maintenance Therapies in Bipolar Disorder
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effectiveness of interpersonal and social rhythm therapy IPSRT versus clinical status and symptom response therapy CSSRT in reinforcing the treatment of bipolar disorder in individuals who are currently undergoing medication treatment for the disorder
Detailed Description:
Bipolar disorder is a serious medical illness that causes shifts in a persons mood energy and ability to function These changes are drastic and can result in damaged relationships poor job or school performance and suicide Bipolar disorder is also known as manic-depressive disorder because it is characterized by episodes of mania and depression Some signs and symptoms of a manic episode include the following increased energy activity and restlessness excessively high overly good mood and extreme irritability Some signs and symptoms of a depressive episode include the following sad anxious or empty mood feelings of hopelessness or pessimism and feelings of guilt worthlessness or helplessness Bipolar disorder is most effectively treated using a strategy that combines medication and psychosocial treatment This study will evaluate the effectiveness of IPSRT versus CSSRT in reinforcing the treatment of bipolar disorder in individuals who are currently undergoing maintenance medication treatment for the disorder
Participants in this open-label study will be randomly assigned to one of two treatment strategies IPSRT or CSSRT All participants will attend study visits once a week until they have been stable for 4 weeks acute phase At this point they will attend study visits every other week for 12 weeks continuation phase and then once a month for 18 months or until another depressive or mixed episode occurs maintenance phase Participants who experience a recurrence will be treated with medication and the type of therapy they were assigned upon study entry IPSRT or CSSRT These participants will continue to be followed for a period of time equivalent to their remainder of time in the study had they not experienced a recurrence Outcomes will be measured at Week 12 of the continuation phase and Week 18 of the maintenance phase
Participants in this open-label study will be randomly assigned to one of two treatment strategies IPSRT or CSSRT All participants will attend study visits once a week until they have been stable for 4 weeks acute phase At this point they will attend study visits every other week for 12 weeks continuation phase and then once a month for 18 months or until another depressive or mixed episode occurs maintenance phase Participants who experience a recurrence will be treated with medication and the type of therapy they were assigned upon study entry IPSRT or CSSRT These participants will continue to be followed for a period of time equivalent to their remainder of time in the study had they not experienced a recurrence Outcomes will be measured at Week 12 of the continuation phase and Week 18 of the maintenance phase
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 950310 | None | None | None |